1. Home
  2. PHGE vs MOGO Comparison

PHGE vs MOGO Comparison

Compare PHGE & MOGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PHGE
  • MOGO
  • Stock Information
  • Founded
  • PHGE 2015
  • MOGO 2003
  • Country
  • PHGE Israel
  • MOGO Canada
  • Employees
  • PHGE N/A
  • MOGO N/A
  • Industry
  • PHGE Biotechnology: Pharmaceutical Preparations
  • MOGO
  • Sector
  • PHGE Health Care
  • MOGO
  • Exchange
  • PHGE Nasdaq
  • MOGO Nasdaq
  • Market Cap
  • PHGE 26.5M
  • MOGO 24.5M
  • IPO Year
  • PHGE N/A
  • MOGO N/A
  • Fundamental
  • Price
  • PHGE $0.75
  • MOGO $1.34
  • Analyst Decision
  • PHGE Strong Buy
  • MOGO Strong Buy
  • Analyst Count
  • PHGE 2
  • MOGO 1
  • Target Price
  • PHGE $22.50
  • MOGO $6.00
  • AVG Volume (30 Days)
  • PHGE 151.9K
  • MOGO 143.7K
  • Earning Date
  • PHGE 11-14-2024
  • MOGO 11-06-2024
  • Dividend Yield
  • PHGE N/A
  • MOGO N/A
  • EPS Growth
  • PHGE N/A
  • MOGO N/A
  • EPS
  • PHGE N/A
  • MOGO N/A
  • Revenue
  • PHGE N/A
  • MOGO $30,995,226.00
  • Revenue This Year
  • PHGE N/A
  • MOGO N/A
  • Revenue Next Year
  • PHGE N/A
  • MOGO $12.48
  • P/E Ratio
  • PHGE N/A
  • MOGO N/A
  • Revenue Growth
  • PHGE N/A
  • MOGO N/A
  • 52 Week Low
  • PHGE $0.62
  • MOGO $0.94
  • 52 Week High
  • PHGE $8.55
  • MOGO $2.25
  • Technical
  • Relative Strength Index (RSI)
  • PHGE 36.37
  • MOGO 60.95
  • Support Level
  • PHGE $0.67
  • MOGO $0.95
  • Resistance Level
  • PHGE $0.81
  • MOGO $1.95
  • Average True Range (ATR)
  • PHGE 0.09
  • MOGO 0.13
  • MACD
  • PHGE 0.00
  • MOGO 0.05
  • Stochastic Oscillator
  • PHGE 44.00
  • MOGO 39.60

About PHGE BiomX Inc. COmmon Stock

BiomX Inc is a clinical-stage microbiome company based in Israel. The company is engaged in developing both natural and engineered phage cocktails designed to target and destroy harmful bacteria that affect the appearance of the skin, as well as harmful bacteria in chronic diseases, such as inflammatory bowel disease, colorectal cancer, and primary sclerosing cholangitis. BX004 is its therapeutic phage product candidate under development for chronic pulmonary infections caused by Pseudomonas aeruginosa, or P. aeruginosa, a main contributor to morbidity and mortality in patients with CF.

About MOGO Mogo Inc.

Mogo Inc is a Canadian-based financial technology company. It offers a finance application to consumers with solutions that help them to control their financial health. At Mogo, users can sign up for a free account and get access to products and solutions that help users to monitor their credit score, protect themselves from identity fraud, control their spending, and borrow responsibly. Company offers digital loans and mortgages and also offer a digital payments platform that powers next-generation card programs for both established global corporations and innovative fintech companies in Europe and Canada.

Share on Social Networks: